Adiuvo Investment SA engages in financing of the research and development projects in the area of biomedicine. It operates through the following segments: Nutraceutical Platform, Medical Devices Platform, and Exploration Projects. The Nutraceutical Platform segment develops over-the-counter functional pharmaceutical products. The Medical Devices Platform segment is involved in the creation of disposable medical tools. The Exploration Projects segment pertains to the financing of long-term research projects. The company was founded by Marek Jan Orlowski in 2013 and is headquartered in Warsaw, Poland.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company